ZA961481B - Isolated nonapeptides presented by hla molecules and uses thereof - Google Patents
Isolated nonapeptides presented by hla molecules and uses thereofInfo
- Publication number
- ZA961481B ZA961481B ZA961481A ZA961481A ZA961481B ZA 961481 B ZA961481 B ZA 961481B ZA 961481 A ZA961481 A ZA 961481A ZA 961481 A ZA961481 A ZA 961481A ZA 961481 B ZA961481 B ZA 961481B
- Authority
- ZA
- South Africa
- Prior art keywords
- presented
- hla molecules
- nonapeptides
- isolated
- isolated nonapeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/393,273 US6222012B1 (en) | 1992-08-31 | 1995-02-23 | Isolated nonapeptides presented by HLA molecules, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA961481B true ZA961481B (en) | 1996-07-23 |
Family
ID=23554022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA961481A ZA961481B (en) | 1995-02-23 | 1996-02-23 | Isolated nonapeptides presented by hla molecules and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US6222012B1 (xx) |
EP (1) | EP0811013A4 (xx) |
JP (1) | JP3096739B2 (xx) |
CN (1) | CN1175954A (xx) |
AU (1) | AU693664B2 (xx) |
CA (1) | CA2213337A1 (xx) |
NZ (1) | NZ303414A (xx) |
WO (1) | WO1996026214A1 (xx) |
ZA (1) | ZA961481B (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157091B1 (en) * | 1999-06-18 | 2007-01-02 | Ludwig Institute For Cancer Research | MAGE-A1 peptides presented by HLA class II molecules |
WO2001030382A1 (en) | 1999-10-22 | 2001-05-03 | Aventis Pasteur Limited | Method of inducing and/or enhancing an immune response to tumor antigens |
AU2001229681A1 (en) * | 2000-01-20 | 2001-07-31 | Ludwig Institute For Cancer Research | Mage antigenic peptides which bind hla-b35 and hla-b44 |
DK1282702T3 (da) | 2000-05-10 | 2007-04-02 | Sanofi Pasteur Ltd | Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf |
ATE531729T1 (de) * | 2002-09-12 | 2011-11-15 | Oncotherapy Science Inc | Kdr-peptide und diese enthaltende impfstoffe |
US7338670B2 (en) | 2005-04-14 | 2008-03-04 | Duke University | Use of an agent that restores tissue perfusion and oxygenation |
JP5799394B2 (ja) | 2009-03-18 | 2015-10-28 | オンコセラピー・サイエンス株式会社 | Neil3ペプチドおよびそれを含むワクチン |
GB201120860D0 (en) | 2011-12-05 | 2012-01-18 | Cambridge Entpr Ltd | Cancer immunotherapy |
WO2016094309A1 (en) | 2014-12-10 | 2016-06-16 | Myosotis | Inhibition of tnf signaling in cancer immunotherapy |
MX2017016844A (es) | 2015-07-16 | 2018-08-15 | Biokine Therapeutics Ltd | Composiciones y procedimientos para tratar cancer. |
GB201519340D0 (en) | 2015-11-02 | 2015-12-16 | Cambridge Entpr Ltd | Methods of T-lymphocyte expansion |
GB201519481D0 (en) | 2015-11-04 | 2015-12-16 | Cancer Rec Tech Ltd | Immunomodulatory antibodies |
GB201616238D0 (en) | 2016-09-23 | 2016-11-09 | Adaptimmune Ltd | Modified T cells |
DK3565579T3 (da) | 2017-01-05 | 2023-09-04 | Kahr Medical Ltd | Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf |
HRP20220230T1 (hr) | 2017-01-05 | 2022-04-29 | Kahr Medical Ltd. | Sirp1 alfa-41bbl fuzijski protein i metoda njegove upotrebe |
GB201700345D0 (en) | 2017-01-09 | 2017-02-22 | F-Star Beta Ltd | Conditional agonists of immune responses |
IL250916A0 (en) | 2017-03-02 | 2017-06-29 | Geiger Benjamin | Methods for growing t cells in culture and their use |
US20210187023A1 (en) | 2017-06-27 | 2021-06-24 | The Trustees Of Princeton University | Compositions And Methods For Enhancing Immunotherapy |
GB201713078D0 (en) | 2017-08-15 | 2017-09-27 | Adaptimmune Ltd | T Cell Modification |
WO2019145509A1 (en) | 2018-01-26 | 2019-08-01 | Cambridge Enterprise Limited | Peptide exchange protein |
KR20210044220A (ko) | 2018-07-11 | 2021-04-22 | 카 메디컬 리미티드 | SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법 |
GB201811404D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-CD137 Antibodies |
GB201811410D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | OX40 Binding molecules |
GB201811408D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | CD137 Binding Molecules |
WO2020041662A1 (en) | 2018-08-24 | 2020-02-27 | The Trustees Of Princeton University | Immunotherapy with metabolic enzyme expression |
GB201820444D0 (en) | 2018-12-14 | 2019-01-30 | Adaptimmune Ltd | Marker for T cell expansion |
KR20220044284A (ko) | 2019-07-11 | 2022-04-07 | 카 메디컬 리미티드 | 이종이량체 및 이의 사용방법 |
GB201911954D0 (en) | 2019-08-20 | 2019-10-02 | Adaptimmune Ltd | Lentiviral transduction methods |
US20230048361A1 (en) | 2019-12-31 | 2023-02-16 | Kahr Medical Ltd. | Methods of culturing t cells and uses of same |
US20230048719A1 (en) | 2019-12-31 | 2023-02-16 | Kahr Medical Ltd. | Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same |
IL276599A (en) | 2020-08-09 | 2022-03-01 | Yeda Res & Dev | T cell receptor unique to mage-a1 and its uses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986001211A1 (en) * | 1984-08-10 | 1986-02-27 | MERCK Patent Gesellschaft mit beschränkter Haftung | Immunotherapeutic polypeptide agents |
AU8305491A (en) | 1990-08-01 | 1992-03-02 | Cytel Corporation | Novel immunosuppressant peptides |
US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
EP1704868A1 (en) | 1992-08-07 | 2006-09-27 | Pharmexa Inc. | HLA binding peptides and their uses |
US5405940A (en) * | 1992-08-31 | 1995-04-11 | Ludwig Institute For Cancer Research | Isolated nonapeptides derived from MAGE genes and uses thereof |
JP3608788B2 (ja) * | 1992-08-31 | 2005-01-12 | ルドヴィグ・インスティテュート・フォー・キャンサー・リサーチ | Mage−3遺伝子から誘導されてhla−a1により提示される単離されたノナペプチドおよびそれらの用途 |
-
1995
- 1995-02-23 US US08/393,273 patent/US6222012B1/en not_active Expired - Fee Related
-
1996
- 1996-02-01 EP EP96906281A patent/EP0811013A4/en not_active Withdrawn
- 1996-02-01 CN CN96192076A patent/CN1175954A/zh active Pending
- 1996-02-01 AU AU49715/96A patent/AU693664B2/en not_active Ceased
- 1996-02-01 JP JP08525701A patent/JP3096739B2/ja not_active Expired - Fee Related
- 1996-02-01 NZ NZ303414A patent/NZ303414A/xx unknown
- 1996-02-01 CA CA002213337A patent/CA2213337A1/en not_active Abandoned
- 1996-02-01 WO PCT/US1996/001489 patent/WO1996026214A1/en not_active Application Discontinuation
- 1996-02-23 ZA ZA961481A patent/ZA961481B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NZ303414A (en) | 1998-12-23 |
AU693664B2 (en) | 1998-07-02 |
EP0811013A4 (en) | 1998-12-09 |
CA2213337A1 (en) | 1996-08-29 |
CN1175954A (zh) | 1998-03-11 |
US6222012B1 (en) | 2001-04-24 |
WO1996026214A1 (en) | 1996-08-29 |
AU4971596A (en) | 1996-09-11 |
EP0811013A1 (en) | 1997-12-10 |
JPH11500137A (ja) | 1999-01-06 |
JP3096739B2 (ja) | 2000-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA961481B (en) | Isolated nonapeptides presented by hla molecules and uses thereof | |
IL122428A0 (en) | Minizymes and minribozymes and uses thereof | |
GB9525719D0 (en) | Speech system | |
GB2298852B (en) | Suitcase | |
GB2306554B (en) | Clipboard | |
GB9610897D0 (en) | Supercharger | |
GB9503149D0 (en) | Macerator | |
GB2297502B (en) | Harvester-knife cylinder and blower-assist | |
GB9507694D0 (en) | Polycyclic dyes | |
GB2295580B (en) | Notepads | |
GB9523580D0 (en) | Gas analysis | |
CA76504S (en) | Suitcase | |
CA77029S (en) | Sign | |
GB9501868D0 (en) | Assays and uses thereof | |
CA76444S (en) | Portable sign | |
GB9519112D0 (en) | Luggage | |
GB9514002D0 (en) | Flagstaff | |
AU125366S (en) | An ornament | |
AU130384S (en) | An ornament | |
AU130385S (en) | An ornament | |
AU130386S (en) | An ornament | |
AU125360S (en) | An ornament | |
AU125362S (en) | An ornament | |
AU125363S (en) | An ornament | |
AU130383S (en) | An ornament |